E
- Earnings per Share (EPS)
- Profit for the year after tax and minority interests, divided by the weighted average number of Ordinary Shares in issue during the year.
- EEA
- European Economic Area.
- Efficacy
- The benefi cial effect of a drug.
- EFPIA
- European Federation for Pharmaceutical Industries and Associations.
- EMEA
- The European Medicines Agency.
- Epidemiological
- Relating to the study of incidences, distribution, control and prevention of diseases in populations.
- Epidermal Growth Factor (EGF) receptor
- A protein found on the surface of some cells and to which epidermal growth factor binds, causing the cells to divide. It is found at abnormally high levels on the surface of many types of cancer cells, so these cells may divide excessively in the presence of epidermal growth factor.
- EU
- European Union.
- Exceptional items
- Significantly large items that are distinct in nature from items normally occurring during ordinary business activities.
- Excipient
- An inactive substance that serves as the vehicle or medium for a drug or other active substance.
- Extrapyramidal
- Relating to nerve pathways that link nerve nuclei in the surface of the cerebrum (main mass of the brain), basal ganglia (deep within the brain) and parts of the brain stem.
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD
- Stockholm
-
310.10 SEK
At Nov 21, 2009 10:43 AM GMT
Detailed share priceOur responsibility
We continue to communicate openly on a range of issues, including:
